Enovix Surges 17% on Executive Hire; PepsiCo Slips After Earnings

Shares of several U.S. companies made significant moves in premarket trading Thursday, driven by executive appointments, clinical trial data, and quarterly earnings reports.

Key Premarket Movers

Battery technology firm Enovix (ENVX) surged 17% after announcing the appointment of Michael Vyvoda, a former Apple executive, as its new chief operating officer. Vyvoda, who was involved in scaling manufacturing for AirPods at Apple, will now oversee Enovix's global operations as it increases production in Malaysia and South Korea.

Other notable gainers included:

Ad

• Forte Biosciences (FBRX) jumped 12% after the company reported positive Phase 1b results for its vitiligo treatment, FB102. Forte stated the therapy demonstrated a statistically significant improvement compared to a placebo.
• Rackspace Technology (RXT) gained 8% following the announcement of a strategic partnership with Palantir Technologies. The collaboration aims to deploy enterprise artificial intelligence solutions in regulated industries, positioning Rackspace as a preferred implementation partner.

PepsiCo Declines on Mixed Results

In contrast, shares of PepsiCo (PEP) slipped 1.8% after the consumer goods giant reported mixed second-quarter financial results. While the company's revenue surpassed Wall Street estimates, its adjusted earnings per share fell slightly short of analyst expectations, leading to modest selling pressure on the stock.